Abstract:Status epilepticus is an uncommon but life-threatening seizure. Little is known about the risk of recurrent status epilepticus in patients who present with an initial episode. To determine the risk of recurrent status epilepticus in children, we prospectively followed 95 children, identified at the time of their first episode of status epilepticus, for a mean of 29.0 months (range, 4-60 months). The patients' ages ranged from 1 month to 18 years (mean, 4.6 years). The cause of the status epilepticus was classi… Show more
“…In patients with SE, the occurrence of recurrent SE ranges from 10% to 56% in children28, 29, 34, 35 and from 13% to 37% in mixed population of adults and children 8, 9. Predictors of recurrent SE include age < 4 years,8 female gender, nonresponse to first ASM for SE,9 and remote symptomatic and progressive etiologies 9, 35…”
Section: Long‐term Outcomes Of Sementioning
confidence: 99%
“…Predictors of recurrent SE include age < 4 years,8 female gender, nonresponse to first ASM for SE,9 and remote symptomatic and progressive etiologies 9, 35…”
Section: Long‐term Outcomes Of Sementioning
confidence: 99%
“…Long‐term mortality data after an episode of SE, including in‐hospital deaths, is 0%‐22% in children5, 6, 17, 26, 27, 28, 29, 33, 34, 35, 37, 38, 45, 53 and 0%‐57% in adults 10, 11, 12, 17, 19, 20, 43, 54…”
Section: Long‐term Outcomes Of Sementioning
confidence: 99%
“…In children, many studies have pointed out remote29, 35, 36 and acute6, 17, 24, 26, 71 symptomatic causes, progressive encephalopathies,17, 26, 35, 36 or more extensively “nonfebrile‐nonidiopathic SE”28 as predictors of poor outcome. In contrast, the risks of mortality53 and neurological deficits are low with febrile SE and cryptogenic/idiopathic SE 26, 27, 28, 72.…”
SummaryWe reviewed 37 studies reporting long‐term outcomes after a status epilepticus (SE) episode in pediatric and adult populations. Study design, length of follow‐up, outcome measures, domains investigated (mortality, SE recurrence, subsequent epilepsy, cognitive outcome, functional outcome, or quality of life), and predictors of long‐term outcomes are summarized. Despite heterogeneity in the design of prior studies, overall risk of poor long‐term outcome after SE is high in both children and adults. Etiology is the main determinant of outcome, and the effect of age or SE duration is often difficult to distinguish from the underlying cause. The effect of the treatment on long‐term outcome after SE is still unknown.
“…In patients with SE, the occurrence of recurrent SE ranges from 10% to 56% in children28, 29, 34, 35 and from 13% to 37% in mixed population of adults and children 8, 9. Predictors of recurrent SE include age < 4 years,8 female gender, nonresponse to first ASM for SE,9 and remote symptomatic and progressive etiologies 9, 35…”
Section: Long‐term Outcomes Of Sementioning
confidence: 99%
“…Predictors of recurrent SE include age < 4 years,8 female gender, nonresponse to first ASM for SE,9 and remote symptomatic and progressive etiologies 9, 35…”
Section: Long‐term Outcomes Of Sementioning
confidence: 99%
“…Long‐term mortality data after an episode of SE, including in‐hospital deaths, is 0%‐22% in children5, 6, 17, 26, 27, 28, 29, 33, 34, 35, 37, 38, 45, 53 and 0%‐57% in adults 10, 11, 12, 17, 19, 20, 43, 54…”
Section: Long‐term Outcomes Of Sementioning
confidence: 99%
“…In children, many studies have pointed out remote29, 35, 36 and acute6, 17, 24, 26, 71 symptomatic causes, progressive encephalopathies,17, 26, 35, 36 or more extensively “nonfebrile‐nonidiopathic SE”28 as predictors of poor outcome. In contrast, the risks of mortality53 and neurological deficits are low with febrile SE and cryptogenic/idiopathic SE 26, 27, 28, 72.…”
SummaryWe reviewed 37 studies reporting long‐term outcomes after a status epilepticus (SE) episode in pediatric and adult populations. Study design, length of follow‐up, outcome measures, domains investigated (mortality, SE recurrence, subsequent epilepsy, cognitive outcome, functional outcome, or quality of life), and predictors of long‐term outcomes are summarized. Despite heterogeneity in the design of prior studies, overall risk of poor long‐term outcome after SE is high in both children and adults. Etiology is the main determinant of outcome, and the effect of age or SE duration is often difficult to distinguish from the underlying cause. The effect of the treatment on long‐term outcome after SE is still unknown.
“…Infection with fever is by far the most common etiology in children, and alcohol use is rare, but the diversity of etiologies in childhood is similar to adults. The risk of recurrence is greatest (40% to 6Wo) in children with acute and chronic CNS insults and least (4%) in those with idiopathic causes or febrile status (15). The etiology is highly age dependent in the pediatric age group.…”
Section: Risk Factors For Occurrence Of Gcsementioning
Summary: Status epilepticus is common and associated with significant mortality and complications. It affects approximately 50 patients per 100,000 population annually and recurs in >13%. History of epilepsy is the strongest single risk factor for generalized convulsive status epilepticus. More than 15% of patients with epilepsy have at least one episode of status epilepticus and low antiepileptic drug levels are a potentially modifiable risk factor. Other risks include young age, genetic predisposition, and acquired brain insults. Fever is a very common risk in children, as is stroke in adults. Mortality rates are 15% to 20% in adults and 3% to 15% in children. Acute complications result from hyperthermia, pulmonary edema, cardiac arrhythmias, and cardiovascular collapse. Long‐term complications include epilepsy (20% to 40%), encephalopathy (6% to 15%), and focal neurologic deficits (9% to 11%). Neuronal injury leading to temporal lobe epilepsy is probably mediated by excess excitation via activation of the N‐methyl‐D‐aspartate (NMDA) subtype of glutamate receptors and consequent elevated intracellular calcium that causes acute necrosis and delayed apoptotic cell death. Some forms of nonconvulsive status epilepticus may also lead to neuronal injury by this mechanism, but others may not. Based on clinical and experimental observations, complex partial status epilepticus is more likely to result in neuronal injury similar to generalized convulsive status epilepticus. Absence status epilepticus is much less likely to result in neuronal injury, and complications because it may be mediated primarily through excess inhibition. Future research strategies to prevent complications of status epilepticus include the study of new drugs (including NMDA antagonists, new drug delivery systems, and drug combinations) to stop seizure activity and prevent acute and delayed neuronal injury that leads to the development of epilepsy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.